Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA + Atorvastatin in AEH and EEC
NCT05675787Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in Atypical endometrial hyperplasia (AEH), endometrial carcinoma, sponsored by Peking University People's Hospital. Started Jan 2023; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
Atypical endometrial hyperplasia (AEH)endometrial carcinoma
Beyond the preview
Go deeper on NCT05675787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05675787.